When we eat certain foods, our genes change. This, in turn, changes how we react to certain nutrients in food. Nutrigenomics is a branch of genetics that studies this. Nutrigenomics testing helps people find and evaluate certain genetic markers, and it then comes up with a full report with suggestions for how to get to a certain level of fitness. The testing helps people find places where they aren’t getting enough energy from their food, which can lead to diseases like diabetes. The more people learn about the benefits of nutrigenomics testing, the more money the market will make in the future. In addition, people are becoming more concerned about their health and fitness, and healthy food is becoming more important to help prevent chronic diseases like diabetes and heart disease. People who are into sports and personalised nutrition are also becoming more interested in the market’s revenue growth over the next few years.
There are, however, things that could slow down the market’s revenue growth over the next few years, like the high cost of nutrigenomics testing, the lack of skilled doctors, and concerns about the privacy of an individual’s genetic information.
To get the report, click here: https://www.zionmarketresearch.com/report/nutrigenomics-market.
COVID-19’s Impact Study
- Businesses and operations were seriously harmed by social isolation and restrictions.
- In transportation and logistics, there were problems because of lockdowns
- Manufacturing and mining operations around the world were affected.
- Took a toll on the economy of different countries.
- Caused a sudden and drastic drop in economic activity.
- Disrupted farming, fisheries, dairy, and other industries.
- Caused job loss and a financial crisis.
- Due to a decrease in disposable income, the supply effects were even worse.
- Variants keep popping up, which makes people worried and changes their normal routines.
Revenue from the Obesity Segment is expected to grow quickly.
Obesity is expected to be the fastest-growing segment in terms of revenue over the next few years because of the rise in obesity due to a sedentary lifestyle and the growing popularity of street food. If you’re overweight or obese, the World Health Organization says that at least 2.8 million people die each year because they are overweight or obese. Low- and middle-income countries are now more likely to be obese than high-income countries were in the past.
The Reagents and Kits Segment is going to make a lot of money.
Revenue from reagents and kits is expected to grow a lot over the next few years. Consumers are becoming more interested in personalised nutrition, which means more people will want to buy nutrigenomic testing kits, which help people find a diet that is right for them based on their phenotype, genetic, and medical information. These kits help people plan a healthy diet, cut down on the risk of certain illnesses, and improve their health.
North America to Account for Largest Revenue Share
Over the next few years, the global market for nutrigenomics is expected to grow the most. This is because more people are using personal genomics, obesity and diabetes are becoming more common, and research is ongoing into nutrigenomics techniques. Further, there are a lot of big companies in the region, and there is a lot of demand for healthy food because it’s good for you.
Major Companies in the Market Include:
- Koninklijke DSM N.V.
- BASF SE
- Danone S.A.
- Unilever plc
- Genova Diagnostics
- Nutrigenomix Inc.
- Metagenics, Inc.
- GX Sciences Inc.
- Xcode Life
The global nutrigenomics market is segmented on the basis of application, product, and region:
- Cardiovascular Diseases
- Cancer Research
- Reagents and Kits
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA